Skip to main content
British Heart Journal logoLink to British Heart Journal
. 1994 Feb;71(2):129–134. doi: 10.1136/hrt.71.2.129

Dipyridamole is superior to dobutamine for thallium stress imaging: a randomised crossover study.

E B Kumar 1, S A Steel 1, S Howey 1, J L Caplin 1, C P Aber 1
PMCID: PMC483631  PMID: 8130019

Abstract

OBJECTIVE--To assess the value of dobutamine over dipyridamole as a pharmacological stressing agent in myocardial perfusion imaging with thallium-201. DESIGN--Stress and redistribution tomographic images were taken in a group of patients in a randomised crossover study of both agents. The scans were scored to give a value for the stress and redistribution images and a reversibility score (redistribution--stress). All patients had coronary angiography that was also scored. Differences between the two agents were compared by a paired t test. PATIENTS--30 patients aged 51-70 years with chest pain thought to be caused by myocardial ischaemia. 11 had had previously myocardial infarction. RESULTS--Dipyridamole caused adverse symptoms in six patients whereas dobutamine caused symptoms in 21 patients (chi 2 = 15.15, p < 0.0001). Dobutamine stress took considerably longer than dipyridamole (31 v 6 minutes) and cost more (17 pounds v 1.50 pounds). There were no significant differences between the agents in terms of total stress or redistribution scores, but regional analysis showed that dipyridamole showed significantly more defects during stress at the apex and lateral wall (p < 0.05), with no significant difference at redistribution. Dipyridamole stress also caused significantly more reversible defects at the apex (p < 0.05) and gave a better correlation than dobutamine with coronary score (dipyridamole r = 0.80, p < 0.001 v dobutamine r = 0.64, p < 0.001). In six patients who had continued to take beta blockers the results of dobutamine stress did not correlate with coronary score, r = 0.34 (NS), whereas dipyridamole studies were not affected. CONCLUSION--Compared with dobutamine, dipyridamole was as effective in producing overall perfusion defects and more effective in provoking defects at the apex and lateral segment. The dipyridamole study correlated better with coronary score and was not affected by concurrent beta blocker treatment. It was also better tolerated by the patients, was less time consuming, and was much cheaper.

Full text

PDF
129

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beller G. A. Dipyridamole thallium-201 scintigraphy: an excellent alternative to exercise scintigraphy. J Am Coll Cardiol. 1989 Dec;14(7):1642–1644. doi: 10.1016/0735-1097(89)90009-0. [DOI] [PubMed] [Google Scholar]
  2. Berthe C., Pierard L. A., Hiernaux M., Trotteur G., Lempereur P., Carlier J., Kulbertus H. E. Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol. 1986 Dec 1;58(13):1167–1172. doi: 10.1016/0002-9149(86)90376-0. [DOI] [PubMed] [Google Scholar]
  3. Bonaduce D., Muto P., Morgano G., Pace L., Ferrara N., Salvatore M., Condorelli M. Effect of beta-blockade on thallium-201 dipyridamole myocardial scintigraphy. Acta Cardiol. 1984;39(6):399–408. [PubMed] [Google Scholar]
  4. Bridges A. B., Kennedy N., McNeill G. P., Cook B., Pringle T. H. The effect of atenolol on dipyridamole 201Tl myocardial perfusion tomography in patients with coronary artery disease. Nucl Med Commun. 1992 Jan;13(1):41–46. doi: 10.1097/00006231-199201000-00007. [DOI] [PubMed] [Google Scholar]
  5. Chambers C. E., Brown K. A. Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants. J Am Coll Cardiol. 1988 Jul;12(1):37–41. doi: 10.1016/0735-1097(88)90353-1. [DOI] [PubMed] [Google Scholar]
  6. Coma-Canella I. Sensitivity and specificity of dobutamine--electrocardiography test to detect multivessel disease after acute myocardial infarction. Eur Heart J. 1990 Mar;11(3):249–257. doi: 10.1093/oxfordjournals.eurheartj.a059691. [DOI] [PubMed] [Google Scholar]
  7. Freeman M. L., Palac R., Mason J., Barnes W. E., Eastman G., Virupannavar S., Loeb H. S., Kaplan E. A comparison of dobutamine infusion and supine bicycle exercise for radionuclide cardiac stress testing. Clin Nucl Med. 1984 May;9(5):251–255. doi: 10.1097/00003072-198405000-00001. [DOI] [PubMed] [Google Scholar]
  8. Iskandrian A. S., Heo J. Myocardial ischemia during pharmacologic coronary vasodilatation: a concept in search of definition. Cathet Cardiovasc Diagn. 1989 Oct;18(2):65–66. doi: 10.1002/ccd.1810180202. [DOI] [PubMed] [Google Scholar]
  9. Ker M. Issues in the use of kappa. Invest Radiol. 1991 Jan;26(1):78–83. doi: 10.1097/00004424-199101000-00015. [DOI] [PubMed] [Google Scholar]
  10. Leaman D. M., Brower R. W., Meester G. T., Serruys P., van den Brand M. Coronary artery atherosclerosis: severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation. 1981 Feb;63(2):285–299. doi: 10.1161/01.cir.63.2.285. [DOI] [PubMed] [Google Scholar]
  11. Leppo J., Boucher C. A., Okada R. D., Newell J. B., Strauss H. W., Pohost G. M. Serial thallium-201 myocardial imaging after dipyridamole infusion: diagnostic utility in detecting coronary stenoses and relationship to regional wall motion. Circulation. 1982 Sep;66(3):649–657. doi: 10.1161/01.cir.66.3.649. [DOI] [PubMed] [Google Scholar]
  12. Mannering D., Cripps T., Leech G., Mehta N., Valantine H., Gilmour S., Bennett E. D. The dobutamine stress test as an alternative to exercise testing after acute myocardial infarction. Br Heart J. 1988 May;59(5):521–526. doi: 10.1136/hrt.59.5.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mason J. R., Palac R. T., Freeman M. L., Virupannavar S., Loeb H. S., Kaplan E., Gunnar R. M. Thallium scintigraphy during dobutamine infusion: nonexercise-dependent screening test for coronary disease. Am Heart J. 1984 Mar;107(3):481–485. doi: 10.1016/0002-8703(84)90089-9. [DOI] [PubMed] [Google Scholar]
  14. Meyer S. L., Curry G. C., Donsky M. S., Twieg D. B., Parkey R. W., Willerson J. T. Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery disease. Am J Cardiol. 1976 Jul;38(1):103–108. doi: 10.1016/0002-9149(76)90070-9. [DOI] [PubMed] [Google Scholar]
  15. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  16. Wackers F. J. Pharmacologic stress with dipyridamole: how lazy can one be? J Nucl Med. 1990 Jun;31(6):1024–1027. [PubMed] [Google Scholar]
  17. Zeller F. P., Blend M. J. The use of intravenous dipyridamole in thallium 201 myocardial perfusion imaging. Pharmacotherapy. 1987;7(5):178–184. doi: 10.1002/j.1875-9114.1987.tb04047.x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES